Independent nonprofit center on health security, AI and PH research
Bloomberg reports a telehealth company has disclosed plans to sell already allowed compounds such as sermorelin and glutathione, which patients pursue for wellness benefits despite limited clinical evidence. The move underscores ongoing tensions between patient demand and scientific validation.
A Russian lab worker has died amid reports of pneumonic plague in Irkutsk. The case has prompted quarantines and widespread monitoring as officials assess risk to the general population. U.S. and international health authorities are watching closely while cautioning that immediate threats remain limited.